Table 5.
|
|
rPBP3
a
|
Bla
b
|
Proportions (%) of isolates and patients
c
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
STs | n | n | % | n | % |
Anatomical sites |
Age groups |
Hospitalized d | |||
Eye | Ear | Respiratory | 0-3 | ≥50 | |||||||
ST367 |
29 |
29 |
100 |
0 |
0 |
17 |
17 |
59 |
28 |
34 |
28 |
ST396 |
16 |
16 |
100 |
5 |
31 |
56
e
|
6 |
38 |
81
f
|
13 |
38 |
ST201 |
15 |
15 |
100 |
0 |
0 |
53
e
|
0 |
47 |
47 |
27 |
47 |
ST159 |
12 |
1 |
8 |
0 |
0 |
8 |
8 |
75 |
33 |
42 |
50 |
ST14 |
11 |
11 |
100 |
1 |
9 |
18 |
0 |
73 |
64 |
9 |
55 |
ST12 |
8 |
7 |
88 |
0 |
0 |
50 |
13 |
38 |
38 |
13 |
25 |
ST395 |
8 |
0 |
0 |
0 |
0 |
63
e
|
0 |
25 |
63 |
25 |
0 |
ST57 |
6 |
4 |
67 |
3 |
50 |
33 |
17 |
50 |
83 |
17 |
33 |
Other STs |
91 |
33 |
36 |
7 |
8 |
19 |
16 |
60 |
58 |
19 |
25 |
All STs | 196 | 116 | 59 | 16 | 8 | 27 | 12 | 56 | 46 | 22 | 31 |
aPBP3-mediated resistance (see Table 1).
bBeta-lactamase positive (all TEM-1).
cProportions for each ST were compared with the proportions for other STs (e.g. ST396 versus non-ST396) using Fisher’s exact test. Characteristics significantly more prevalent in particular STs are indicated (bold).
dProportions of patients hospitalized at the time of sampling.
ep < 0.05.
fp = 0.004.